The Jeuveau™ launch campaign in the U.S. includes the promotional hashtag #NEWTOX. Jeuveau™ is a modern-made neurotoxin and the first and only neurotoxin dedicated exclusively to aesthetics.1,2 It is an injectable treatment approved by the FDA for the temporary improvement in the appearance of moderate to severe frown lines in adults.
We are one of the first practices to offer this exclusive treatment.
Jeuveau™ is a prescription medicine that is injected into muscles and used in adults for a short period of time (temporary) to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines).
Launched in the US under the promotional hashtag #NEWTOX, Jeuveau™ is a modern-made neurotoxin and the first and only neurotoxin approved exclusively for aesthetics.1,2 There is a lot of excitement about Jeuveau™ as it’s the first neurotoxin to hit the U.S. market in almost a decade.2 Furthermore, Jeuveau™ has also been studied in the largest head-to-head clinical trial versus Botox™ Cosmetic.
The most commonly reported side effects in clinical trials include headache, eyelid drooping, upper respiratory tract infection and increased white blood cell count.2 No serious drug-related events were observed in the studies.